Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Gains from Sales and Divestitures (2016 - 2017)

Historic Gains from Sales and Divestitures for Ocugen (OCGN) over the last 3 years, with Q4 2017 value amounting to $1889.0.

  • Ocugen's Gains from Sales and Divestitures fell 4277.49% to $1889.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $1889.0, marking a year-over-year decrease of 4277.49%. This contributed to the annual value of $1889.0 for FY2017, which is 4277.49% down from last year.
  • Per Ocugen's latest filing, its Gains from Sales and Divestitures stood at $1889.0 for Q4 2017, which was down 4277.49% from $1889.0 recorded in Q3 2017.
  • Ocugen's Gains from Sales and Divestitures' 5-year high stood at $3303.0 during Q4 2015, with a 5-year trough of $1889.0 in Q2 2015.
  • For the 3-year period, Ocugen's Gains from Sales and Divestitures averaged around $2203.0, with its median value being $1889.0 (2015).
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first changed by 0.0% in 2016, then crashed by 4277.49% in 2017.
  • Ocugen's Gains from Sales and Divestitures (Quarter) stood at $3303.0 in 2015, then fell by 0.06% to $3301.0 in 2016, then tumbled by 42.77% to $1889.0 in 2017.
  • Its Gains from Sales and Divestitures stands at $1889.0 for Q4 2017, versus $1889.0 for Q3 2017 and $1889.0 for Q2 2017.